FDA Ortho Panel Gives Advice On Spinal Device Trial Design
This article was originally published in The Gray Sheet
Executive Summary
FDA should be flexible in its protocol guidelines for clinical trials of implanted devices for treating mild to moderate back pain, members of FDA's Orthopaedic & Rehabilitation Devices Panel agreed Sept. 9